Characterization of the interaction of lassa fever virus with its cellular receptor α-dystroglycan

Journal of Virology

Volumn 79, Issue 10, 2005, Pages 5979-5987

  Kunz, Stefan ^a   Rojek, Julian M ^a   Perez, Mar ^a   Spiropoulou, Christina F ^b   Oldstone, Michael B A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ALPHA DYSTROGLYCAN; CELL SURFACE RECEPTOR; DYSTROGLYCAN; LAMININ; LAMININ ALPHA1; LAMININ ALPHA2; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

ARENAVIRUS; ARTICLE; BINDING AFFINITY; BINDING SITE; CLONE; CONTROLLED STUDY; CYTOSKELETON; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; LASSA VIRUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; RECEPTOR BINDING; VESICULAR STOMATITIS VIRUS; VIRUS ISOLATION; VIRUS RECOMBINANT; VIRUS TYPING;

BINDING SITES; DYSTROGLYCANS; HELA CELLS; HUMANS; LASSA FEVER; LASSA VIRUS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, VIRUS; VIRUS REPLICATION;

CHORIOMENINGITIS VIRUS; LASSA FEVER VIRUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MURINAE; OLD WORLD ARENAVIRUSES; VESICULAR STOMATITIS VIRUS;

EID: 18144366555     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.10.5979-5987.2005     Document Type: Article

References (66)

1. Ahmed, R., A. Salmi, L. D. Butler, J. M. Chiller, and M. B. Oldstone. 1984. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence. J. Exp. Med. 160:521-540.
2. Baize, S., J. Kaplon, C. Faure, D. Pannetier, M. C. Georges-Courbot, and V. Deubel. 2004. Lassa virus infection of human dendritic cells and macrophages is productive but fails to activate cells. J. Immunol. 172:2861-2869.
3. Belkin, A. M., and K. Burridge. 1995. Association of aciculin with dystrophin and utrophin. J. Biol. Chem. 270:6328-6337.
4. Belkin, A. M., and K. Burridge. 1995. Localization of utrophin and aciculin at sites of cell-matrix and cell-cell adhesion in cultured cells. Exp. Cell Res. 221:132-140.
5. Belkin, A. M., and N. R. Smalheiser. 1996. Localization of cranin (dystroglycan) at sites of cell-matrix and cell-cell contact: recruitment to focal adhesions is dependent upon extracellular ligands. Cell Adhes. Commun. 4:281-296.
6. Borrow, P., and M. B. Oldstone. 1992. Characterization of lymphocytic choriomeningitis virus-binding protein(s): a candidate cellular receptor for the virus. J. Virol. 66:7270-7281.
7. Buchmeier, M. J., M. D. Bowen, and C. J. Peters. 2001. Arenaviridae: the viruses and their replication, p. 1635-1668. In B. N. Fields, D. L. Knipe, and P. M. Howley (ed.), Fields virology. Lippincott-Raven, Philadelphia, Pa.
8. Cao, W., M. D. Henry, P. Borrow, H. Yamada, J. H. Elder, E. V. Ravkov, S. T. Nichol, R. W. Compans, K. P. Campbell, and M. B. Oldstone. 1998. Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. Science 282:2079-2081.
9. Cavaldesi, M., G. Macchia, S. Barca, P. Defilippi, G. Tarone, and T. C. Petrucci. 1999. Association of the dystroglycan complex isolated from bovine brain synaptosomes with proteins involved in signal transduction. J. Neurochem. 72:1648-1655.
10. Durbeej, M., M. D. Henry, M. Ferletta, K. P. Campbell, and P. Ekblom. 1998. Distribution of dystroglycan in normal adult mouse tissues. J. Histochem. Cytochem. 46:449-457.
11. Dutko, F. J., and M. B. Oldstone. 1983. Genomic and biological variation among commonly used lymphocytic choriomeningitis virus strains. J. Gen. Virol. 64:1689-1698.
12. Ervasti, J. M., and K. P. Campbell. 1991. Membrane organization of the dystrophin-glycoprotein complex. Cell 66:1121-1131.
13. Ervasti, J. M., and K. P. Campbell. 1993. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J. Cell Biol. 122:809-823.
14. Fisher-Hoch, S. P., O. Tomori, A. Nasidi, G. I. Perez-Oronoz, Y. Fakile, L. Hutwagner, and J. B. McCormick. 1995. Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice. Br. Med. J. 311:857-859.
15. Freedman, D. O., and J. Woodall. 1999. Emerging infectious diseases and risk to the traveler. Med. Clin. N. Am. 83:865-883, v.
16. Gallaher, W. R., C. DiSimone, and M. J. Buchmeier. 9 February 2001, posting date. The viral transmembrane superfamily: possible divergence of Arenavirus and Filovirus glycoproteins from a common RNA virus ancestor. BMC Microbiol. 1:1. [Online.] http://www.biomedcentral.com.
17. Gee, S. H., F. Montanaro, M. H. Lindenbaum, and S. Carbonetto. 1994. Dystroglycan-alpha, a dystrophin-associated glycoprotein, is a functional agrin receptor. Cell 77:675-686.
18. Henry, M. D., and K. P. Campbell. 1998. A role for dystroglycan in basement membrane assembly. Cell 95:859-870.
19. Henry, M. D., J. S. Satz, C. Brakebusch, M. Costell, E. Gustafsson, R. Fassler, and K. P. Campbell. 2001. Distinct roles for dystroglycan, beta1 integrin and perlecan in cell surface laminin organization. J. Cell Sci. 114:1137-1144.
20. Holmes, G. P., J. B. McCormick, S. C. Trock, R. A. Chase, S. M. Lewis, C. A. Mason, P. A. Hall, L. S. Brammer, G. I. Perez-Oronoz, M. K. McDonnell et al. 1990. Lassa fever in the United States. Investigation of a case and new guidelines for management. N. Engl. J. Med. 323:1120-1123.
21. Hosokawa, H., H. Ninomiya, Y. Kitamura, K. Fujiwara, and T. Masaki. 2002. Vascular endothelial cells that express dystroglycan are involved in angiogenesis. J. Cell Sci. 115:1487-1496.
22. Ibraghimov-Beskrovnaya, O., J. M. Ervasti, C. J. Leveille, C. A. Slaughter, S. W. Sernett, and K. P. Campbell. 1992. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355:696-702.
23. Isaacson, M. 2001. Viral hemorrhagic fever hazards for travelers in Africa. Clin. Infect. Dis. 33:1707-1712.
24. James, M., T. M. Nguyen, C. J. Wise, G. E. Jones, and G. E. Morris. 1996. Utrophin-dystroglycan complex in membranes of adherent cultured cells. Cell Motil. Cytoskelet. 33:163-174.
25. James, M., A. Nuttall, J. L. Ilsley, K. Ottersbach, J. M. Tinsley, M. Sudol, and S. J. Winder. 2000. Adhesion-dependent tyrosine phosphorylation of (beta)-dystroglycan regulates its interaction with utrophin. J. Cell Sci. 113:1717-1726.
26. Johnson, K. M., J. B. McCormick, P. A. Webb, E. S. Smith, L. H. Elliott, and I. J. King. 1987. Clinical virology of Lassa fever in hospitalized patients. J. Infect. Dis. 155:456-464.
27. Kahn, J. S., M. J. Schnell, L. Buonocore, and J. K. Rose. 1999. Recombinant vesicular stomatitis virus expressing respiratory syncytial virus (RSV) glycoproteins: RSV fusion protein can mediate infection and cell fusion. Virology 254:81-91.
28. Kanagawa, M., F. Saito, S. Kunz, T. Yoshida-Moriguchi, R. Barresi, Y. M. Kobayashi, J. Muschler, J. P. Dumanski, D. E. Michele, M. B. Oldstone, and K. P. Campbell. 2004. Molecular recognition by LARGE is essential for expression of functional dystroglycan. Cell 117:953-964.
29. Khurana, T. S., L. M. Kunkel, A. D. Frederickson, S. Carbonetto, and S. C. Watkins. 1995. Interaction of chromosome-6-encoded dystrophin related protein with the extracellular matrix. J. Cell Sci. 108:173-185.
30. Kunz, S., N. Sevilla, D. B. McGavern, K. P. Campbell, and M. B. Oldstone. 2001. Molecular analysis of the interaction of LCMV with its cellular receptor [alpha]-dystroglycan. J. Cell Biol. 155:301-310.
31. Kunz, S., N. Sevilla, J. M. Rojek, and M. B. A. Oldstone. 2004. Use of alternative receptors different than alpha-dystroglycan by selected isolates of lymphocytic choriomeningitis virus. Virology 325:432-445.
32. Lawson, N. D., E. A. Stillman, M. A. Whitt, and J. K. Rose. 1995. Recombinant vesicular stomatitis viruses from DNA. Proc. Natl. Acad. Sci. USA 92:4477-4481.
33. Lenz, O., J. ter Meulen, H. D. Klenk, N. G. Seidah, and W. Garten. 2001. The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/SIP. Proc. Natl. Acad. Sci. USA 98:12701-12705.
34. Li, S., D. Harrison, S. Carbonetto, R. Fassler, N. Smyth, D. Edgar, and P. D. Yurchenco. 2002. Matrix assembly, regulation, and survival functions of laminin and its receptors in embryonic stem cell differentiation. J. Cell Biol. 157:1279-1290.
35. Mahanry, S., K. Hutchinson, S. Agarwal, M. McRae, P. E. Rollin, and B. Pulendran. 2003. Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses. J. Immunol. 170:2797-2801.
36. Matsumura, K., A. Chiba, H. Yamada, H. Fukuta-Ohi, S. Fujita, T. Endo, A. Kobata, L. V. Anderson, I. Kanazawa, K. P. Campbell, and T. Shimizu. 1997. A role of dystroglycan in schwannoma cell adhesion to laminin. J. Biol. Chem. 272:13904-13910.
37. McCormick, J. B., and S. P. Fisher-Hoch. 2002. Lassa fever. Curr. Top. Microbiol. Immunol. 262:75-109.
38. McCormick, J. B., I. J. King, P. A. Webb, K. M. Johnson, R. O'Sullivan, E. S. Smith, S. Trippel, and T. C. Tong. 1987. A case-control study of the clinical diagnosis and course of Lassa fever. J. Infect. Dis. 155:445-455.
39. McCormick, J. B., P. A. Webb, J. W. Krebs, K. M. Johnson, and E. S. Smith. 1987. A prospective study of the epidemiology and ecology of Lassa fever. J. Infect. Dis. 155:437-444.
40. Monath, T. P., V. F. Newhouse, G. E. Kemp, H. W. Setzer, and A. Cacciapuoti. 1974. Lassa virus isolation from Mastomys natalensis rodents during an epidemic in Sierra Leone. Science 185:263-265.
41. Oldstone, M. B. 2002. Biology and pathogenesis of lymphocytic choriomeningitis virus infection. Curr. Top. Microbiol. Immunol. 263:83-117.
42. Parekh, B. S., and M. J. Buchmeier. 1986. Proteins of lymphocytic choriomeningitis virus: antigenic topography of the viral glycoproteins. Virology 153:168-178.
43. Perez, M., M. Watanabe, M. A. Whitt, and J. C. de la Torre. 2001. N-terminal domain of Borna disease virus G (p56) protein is sufficient for virus receptor recognition and cell entry. J. Virol. 75:7078-7085.
44. Rambukkana, A., S. Kunz, J. Min, K. P. Campbell, and M. B. Oldstone. 2003. Targeting Schwann cells by nonlytic arenaviral infection selectively inhibits myelination. Proc. Natl. Acad. Sci. USA 100:16071-16076.
45. Schmitz, H., B. Kohler, T. Laue, C. Drosten, P. J. Veldkamp, S. Gunther, P. Emmerich, H. P. Geisen, K. Fleischer, M. F. Beersma, and A. Hoerauf. 2002. Monitoring of clinical and laboratory data in two cases of imported Lassa fever. Microbes Infect. 4:43-50.
46. Sevilla, N., S. Kunz, A. Holz, H. Lewicki, D. Homann, H. Yamada, K. P. Campbell, J. C. de La Torre, and M. B. Oldstone. 2000. Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells. J. Exp. Med. 192:1249-1260.
47. Sevilla, N., D. B. McGavern, C. Teng, S. Kunz, and M. B. Oldstone. 2004. Viral targeting of hematopoietic progenitors and inhibition of DC maturation as a dual strategy for immune subversion. J. Clin. Investig. 113:737-745.
48. Shimizu, H., H. Hosokawa, H. Ninomiya, J. H. Miner, and T. Masaki. 1999. Adhesion of cultured bovine aortic endothelial cells to laminin-1 mediated by dystroglycan. J. Biol. Chem. 274:11995-12000.
49. Smelt, S. C., P. Borrow, S. Kunz, W. Cao, A. Tishon, H. Lewicki, K. P. Campbell, and M. B. Oldstone. 2001. Differences in affinity of binding of lymphocytic choriomeningitis virus strains to the cellular receptor α-dystroglycan correlate with viral tropism and disease kinetics. J. Virol. 75:448-457.
50. Sotgia, F., G. Bonuccelli, M. Bedford, A. Brancaccio, U. Mayer, M. T. Wilson, R. Campos-Gonzalez, J. W. Brooks, M. Sudol, and M. P. Lisanti. 2003. Localization of phospho-beta-dystroglycan (pY892) to an intracellular vesicular compartment in cultured cells and skeletal muscle fibers in vivo. Biochemistry 42:7110-7123.
51. Sotgla, F., H. Lee, M. T. Bedford, T. Petrucci, M. Sudol, and M. P. Lisanti. 2001. Tyrosine phosphorylation of beta-dystroglycan at its WW domain binding motif, PPxY, recruits SH2 domain containing proteins. Biochemistry 40:14585-14592.
52. Spence, H. J., A. S. Dhillon, M. James, and S. J. Winder. 2004. Dystroglycan, a scaffold for the ERK-MAP kinase cascade. EMBO Rep. 5:484-489.
53. Spiropoulou, C. F., S. Kunz, P. E. Rollin, K. P. Campbell, and M. B. Oldstone. 2002. New World arenavirus clade C, but not clade A and B viruses, utilizes α-dystroglycan as its major receptor. J. Virol. 76:5140-5146.
54. Sugita, S., F. Saito, J. Tang, J. Satz, K. Campbell, and T. C. Sudhof. 2001. A stoichiometric complex of neurexins and dystroglycan in brain. J. Cell Biol. 154:435-445.
55. Takada, A., C. Robison, H. Goto, A. Sanchez, K. G. Murti, M. A. Whitt, and Y. Kawaoka. 1997. A system for functional analysis of Ebola virus glycoprotein. Proc. Natl. Acad. Sci. USA 94:14764-14769.
56. Talts, J. F., Z. Andac, W. Gohring, A. Brancaccio, and R. Timpl. 1999. Binding of the G domains of laminin alpha1 and alpha2 chains and perlecan to heparin, sulfatides, alpha-dystroglycan and several extracellular matrix proteins. EMBO J. 18:863-870.
57. Tatsuo, H., K. Okuma, K. Tanaka, N. Ono, H. Minagawa, A. Takade, Y. Matsuura, and Y. Yanagi. 2000. Virus entry is a major determinant of cell tropism of Edmonston and wild-type strains of measles virus as revealed by vesicular stomatitis virus pseudotypes bearing their envelope proteins. J. Virol. 74:4139-4145.
58. Teng, M. N., P. Borrow, M. B. A. Oldstone, and J. C. de la Torre. 1996. A single amino acid change in the glycoprotein of lymphocytic choriomeningitis virus is associated with the ability to cause growth hormone deficiency syndrome. J. Virol. 70:8438-8443.
59. Uchino, M., A. Kara, Y. Mizuno, M. Fujiki, T. Nakamura, M. Tokunaga, T. Hirano, T. Yamashita, E. Uyama, Y. Ando, S. Mita, and M. Ando. 1996. Distribution of dystrophin and dystrophin-associated protein 43DAG (beta-dystroglycan) in the central nervous system of normal controls and patients with Duchenne muscular dystrophy. Intern. Med. 35:189-194.
60. Walker, D. H., J. B. McCormick, K. M. Johnson, P. A. Webb, G. Komba-Kono, L. H. Elliott, and J. J. Gardner. 1982. Pathologic and virologic study of fatal Lassa fever in man. Am. J. Pathol. 107:349-356.
61. Weber, E. L., and M. J. Buchmeier. 1988. Fine mapping of a peptide sequence containing an antigenic site conserved among arenaviruses. Virology 164:30-38.
62. Whelan, S. P., L. A. Ball, J. N. Barr, and G. T. Wertz. 1995. Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones. Proc. Natl. Acad. Sci. USA 92:8388-8392.
63. Williamson, R. A., M. D. Henry, K. J. Daniels, R. F. Hrstka, J. C. Lee, Y. Sunada, O. Ibraghimov-Beskrovnaya, and K. P. Campbell. 1997. Dystroglycan is essential for early embryonic development: disruption of Reichert's membrane in Dag1-null mice. Hum. Mol. Genet. 6:831-841.
64. Wool-Lewis, R. J., and P. Bates. 1998. Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines. J. Virol. 72:3155-3160.
65. Yamamoto, T., N. Shibata, M. Kanazawa, M. Kobayashi, T. Komori, K. Ikeya, E. Kondo, K. Saito, and M. Osawa. 1997. Localization of laminin subunits in the central nervous system in Fukuyama congenital muscular dystrophy: an immunohistochemical investigation. Acta Neuropathol. 94:173-179.
66. Yang, B., D. Jung, D. Motto, J. Meyer, G. Koretzky, and K. P. Campbell. 1995. SH3 domain-mediated interaction of dystroglycan and Grb2. J. Biol. Chem. 270:11711-11714.